Mark Redd
PhD
Vice President, Research and Development
👥Biography 个人简介
Mark Redd has developed the largest therapeutic phage bank and automated phage susceptibility testing platform that enables rapid personalized phage selection for cancer patients with resistant infections. His work at Adaptive Phage Therapeutics has established the clinical infrastructure for delivering personalized phage therapy at scale. He has contributed to developing FDA regulatory pathways for phage therapeutic products.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Mark Redd 的研究动态
Follow Mark Redd's research updates
留下邮箱，当我们发布与 Mark Redd（Adaptive Phage Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment